CYBB c.158_159delinsAG ;(p.A53E)

Variant ID: X-37642759-CC-AG

NM_000397.3(CYBB):c.158_159delinsAG;(p.A53E)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson's Disease.

Antioxidants (Basel, Switzerland)
Ahuja, Manuj M; Kaidery, Navneet Ammal NA; Dutta, Debashis D; Attucks, Otis C OC; Kazakov, Eliot H EH; Gazaryan, Irina I; Matsumoto, Mitsuyo M; Igarashi, Kazuhiko K; Sharma, Sudarshana M SM; Thomas, Bobby B
Publication Date: 2022-09-09

Variant appearance in text: NOX2: A53E
PubMed Link: 36139853
Variant Present in the following documents:
  • Main text
  • antioxidants-11-01780.pdf
View BVdb publication page



Role of putative second transmembrane region of Nox2 protein in the structural stability and electron transfer of the phagocytic NADPH oxidase.

The Journal Of Biological Chemistry
Picciocchi, Antoine A; Debeurme, Franck F; Beaumel, Sylvain S; Dagher, Marie-Claire MC; Grunwald, Didier D; Jesaitis, Algirdas J AJ; Stasia, Marie-José MJ
Publication Date: 2011-08-12

Variant appearance in text: CGD: A53E
PubMed Link: 21659519
Variant Present in the following documents:
  • Main text
View BVdb publication page